Thrombopoietin

References

• Alexander W. S., Maurer A. B., Novak U., Harrison-Smith M. Tyrosine-599 of the c-Mpl receptor is required for She phosphorylation and the induction of cellular differentiation. EMBO J. 1996a; 15: 6531–6540
   PubMed Web of Science ®Google Scholar
• Alexander W. S., Metcalf D., Dunn A. R. Point mutations within a dimer interface homology domain of c-Mpl induce constitutive receptor activity and tumorigenicity. EMBO J. 1995; 14: 5569–5578
   PubMed Web of Science ®Google Scholar
• Alexander W. S., Roberts A. W., Nicola N. A., Li R., Metacalf D. Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietin receptor c-Mpl. Blood 1996b; 87: 2162–2170
   PubMed Web of Science ®Google Scholar
• Arnold J. T., Daw N. C., Stenberg P. E., Jayawardene D., Srivastava D. K., Jackson C. W. A single injection of pegylated megakaryocyte growth and development factor (MGDF) into mice is sufficient to produce a profound stimulation of megakaryocyte frequency, size and ploidization. Blood 1997; 89: 89–823
   Web of Science ®Google Scholar
• Bacon C. M., Tortolani P. J., Shimosaka A., Rees R. C., Longo D. L., Shea J. J. Thrombopoietin (TPO) induces tyrosine phosphorylation and activation of STAT3 and STAT5. FEBS Lett. 1995; 370: 63–68
   PubMed Web of Science ®Google Scholar
• Banu N., Wang J. F., Deng B., Groopman J. E., Avraham H. Modulation of megakaryocytopoiesis by thrombopoietin: the c-Mpl ligand. Blood 1995; 86: 1331–1338
   PubMed Web of Science ®Google Scholar
• Bartley T. D., Bogenberger J., Hunt P., Li Y.-S., Lu H. S., Martin F., Chang M.-S., Samal B., Nichol J. L., Swift S., Johnson M. J., Hsu R.-Y., Parker V. P., Suggs S., Skrine J. D., Merewether L. A., Clogston C., Hsu E., Hokom M. M., Hornkohl A., Choi E., Pangelinan M., Sun Y., Mar V., McNinch J., Simonet L., Jacobsen F., Xie C., Shutter J., Shute H., Basu R., Selander L., Trollinger D., Sieu L., Padilla D., Trail G., Elliott C., Izumi R., Covey T., Crouse J., Garcia A., Xu W., Del Castillo J., Biron J., Cole S., Hu M. C.-T., Pacifici R., Ponting I., Saris C., Wen D., Yung Y. P., Lin H., Bosselman R. A. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 1994; 77: 1117–1124
   PubMed Web of Science ®Google Scholar
• Basser R. L., Rasko J. E.J., Clarke K., Cebon J., Green M. D., Grigg A. P., Zaleberg J., Cohen B. O., Byrne J., Menchaca D. M., Fox R. M., Begley C. G. Randomised, blinded, placebo-controlled phase I trial of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) with filgrastim after dose-intensive chemotherapy in patients with advanced cancer. Blood 1997; 89: 3118–3128
   PubMed Web of Science ®Google Scholar
• Basser R. L., Rasko J. E.J., Clarke K., Cebon J., Green M. D., Hussein S., Alt C., Menchaca D., Tomita D., Marty J., Fox R. M., Begley C. G. Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer. Lancet 1996; 348: 1279–1281
   PubMed Web of Science ®Google Scholar
• Bazan J. F. Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl. Acad. Sci. USA 1990; 87: 6934–6938
   PubMed Web of Science ®Google Scholar
• Benit L., Courtois G., Charon M., Varlet P., Dusanter-Fourt I., Gisselbrecht S. Characterization of mpl cytoplasmic domain sequences required for myeloproliferative leukemia virus pathogenicity. J. Virol. 1994; 68: 5270–5274
   PubMed Web of Science ®Google Scholar
• Birkmann J., Oez S., Smetak M., Kaiser G., Kappauf H., Gallmeier W. M. Effects of human thrombopoietin alone and in combination with erythropoietin and early-acting cytokines on human mobilized purified CD34progenitor cells cultured in serum-depleted medium. Stem Cells 1997; 15: 18–32
   PubMed Web of Science ®Google Scholar
• Borge O. J., Ramsfjell V., Veiby O. P., Murphy M. J., Jr., Lok S., Jacobsen S. E.W. Thrombopoieitin but not erythropoietin promotes viability and inhibits apoptosis of multipotent murine hematopoietic progenitor cell in vitro. Blood 1996; 88: 2859–2870
   PubMed Web of Science ®Google Scholar
• Borge O. J., Ramsfjell V., Cui L., Jacobsen S. E. Ability of early acting cytokines to directly promote survival and suppress apoptosis of human primitive CD34 + CD38- bone marrow cells with multilineage potential at the single-cell level: key role of thrombopoietin. Blood 1997; 90: 2282–2292
   PubMed Web of Science ®Google Scholar
• Broudy V. C., Lin N. L., Kaushansky K. Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance megakaryocyte colony growth and increases megakaryocyte ploid in vitro. Blood 1995; 85: 1719–1726
   PubMed Web of Science ®Google Scholar
• Broudy V. C., Lin N. L., Sabath D. F., Papayannopoulou T., Kaushansky K. Human platelets display high-affinity receptors for thrombopoietin. Blood 1997; 89: 89–1896
   Web of Science ®Google Scholar
• Carver-Moore K., Broxmeyer H. E., Luoh S.-M., Cooper S., Peng J., Burstein S. A., Moore M. W., deSauvage F. J. Low levels of erythroid and myeloid progenitors in thrombopoietin and c-mpl-deficient mice. Blood 1996; 88: 803–808
   PubMed Web of Science ®Google Scholar
• Chang M.-S., Hsu R.-Y., McNinch J., Copeland N. G., Jenkins N. A. The gene for murine megakaryocyte growth and development factor (thrombopoietin, Thpo) is located on mouse chromosome 16. Genomics 1995; 26: 636–637
   PubMed Web of Science ®Google Scholar
• Chang M., Suen Y., Meng G., Buzby J. S., Bussel J., Shen V., van de Ven C., Cairo M. S. Differential mechanisms in the regulation of endogenous levels of thrombopoietin and interieukin-11 during thrombocytopenia: insight into the regulation of platelet production. Blood 1996; 88: 3354–3362
   PubMed Web of Science ®Google Scholar
• Choi E. S., Hokom M., Bartley T., Li Y. S., Ohashi H., Kato T., Nichol J. L., Skrine J., Knudten A., Chen J., Hornkohl A., Grampp C., Sleeman L., Cole S., Trail G., Hunt P. Recombinant human megakaryocyte growth and development factor (MGDF). a ligand for c-Mpl, produces functional human in vitro. platelet. Stem Cells 1995; 13: 317–322
   PubMed Web of Science ®Google Scholar
• Debili N., Wendling F., Katz A., Guichard J., Breton-Gorius P., Hunt P., Vainchenker W. The Mpl ligand or thrombopoietin or megakaryocyte growth and differentiation factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors. Blood 1995; 86: 2516–2525
   PubMed Web of Science ®Google Scholar
• DeSauvage F. J., Carver-Moore K., Luoh S. M., Ryan A., Dowd M., Eaton D. L., Moore M. W. Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin. J. Exp. Med. 1996; 183: 651–656
   PubMed Web of Science ®Google Scholar
• DeSauvage F. J., Hass P. E., Spencer S. D., Malloy B. E., Gurney A. L., Spencer S. A., Darbonne W. C., Henzel W. J., Wong S. C., Kuang W.-J., Oles K. J., Hultgren B., Solberg L. A., Jr., Goeddel D. V., Eaton D. L. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 1994; 369: 533–538
   PubMed Web of Science ®Google Scholar
• Dorsch M., Fan P. D., Danial N. N., Rothman P. B., Goff S. P. The thrombopoietin receptor can mediate proliferation without activation of the Jak-STAT pathway. J. Exp. Med. 1997; 186: 1947–1955
   PubMed Web of Science ®Google Scholar
• Dorsch M., Fan P. D., Bogenberger J., Goff S. P. TPO and IL-3 induce overlapping but distinct protein tyrosine phosphorylation in a myeloid precursor cell line. Biochem. Biophys. Res. Commun. 1995; 214: 424–431
   PubMed Web of Science ®Google Scholar
• Drachman J. G., Griffin J. D., Kaushansky K. The c-Mpl ligand (thrombopoietin) stimulates tyrosine phosphorylation of Jak2, She and c-Mpl. J. Biol. Chem. 1995; 270: 4979–4982
   PubMed Web of Science ®Google Scholar
• Drachman J. G., Sabath D. F., Fox N. E., Kaushansky K. Thrombopoietin signal transduction in purified murine megakaryocytes. Blood 1997; 89: 483–492
   PubMed Web of Science ®Google Scholar
• Ezumi Y., Takayama H., Okuma M. Thrombopoietin, c-Mpl ligand, induces tyrosine phosphorylation of Tyk2, Jak2, and STAT3, and enhances agonists-induced aggregation in platelet. in vitro. FEBS Lett. 1995; 374: 48–52
   PubMed Web of Science ®Google Scholar
• Fanucchi M., Glaspy J., Crawford J., Garst J., Figlin R., Sheridan W., Menchaca D., Tomita D., Ozer H., Harker L. Effects of polyethylene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelet counts for chemotherapy for lung cancer. N. Engl. J. Med. 1997; 336: 404–409
   PubMed Web of Science ®Google Scholar
• Farese A. M., Hunt P., Boone T., MacVittie T. J. Recombinant human megakaryocyte growth and development factor stimulates thrombocytopoiesis in normal non-human primates. Blood 1995; 86: 86–54
   Web of Science ®Google Scholar
• Farese A. M., Hunt P., Grab L. B., MacVittie T. J. Combined administration of recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor enhances multi-lineage hematopoietic reconstitution in nonhuman primates after radiation induced marrow aplasia. J. Clin. Invest. 1996; 97: 2145–2151
   PubMed Web of Science ®Google Scholar
• Fibbe W. E., Heemskerk D. P.M., Laterveer L., Pruijt J. F.M., Foster D., Kaushansky K., Willemze R. Accelerated reconstitution of platelets and erythrocytes following syngeneic transplantation of bone marrow cells derived from thrombopoietin pretreated donor mice. Blood 1995; 86: 3308–3313
   PubMed Web of Science ®Google Scholar
• Fielder P. J., Hass P., Nagel M., Stefanich E., Widmer R., Bennett G. L., Keller G. A., deSauvage F. J., Eaton D. Human platelets as a model for the binding and degradation of thrombopoietin. Blood 1997; 89: 2782–2788
   PubMed Web of Science ®Google Scholar
• Gainsford T., Roberts A. W., Kimura S., Metcalf D., Dranoff K. C., Mulligan K. C., Begley C. C., Robb L., Alexander W. S. Cytokine production and function in c-mpl-deficient mice: no physiological role for interleukin-3 in residual megakaryocyte and platelet production. Blood 1998; 91: 2745–2752
   PubMed Web of Science ®Google Scholar
• Gordon M. S., Hoffman R. Growth factors affecting human thrombocytopoiesis: potential agents for the treatment of thrombocytopenia. Blood 1992; 80: 302–307
   PubMed Web of Science ®Google Scholar
• Grossmann A., Lenox J., Deisher T. A., Ren H. P., Humes J. M., Kaushansky K., Sprugel K. H. Synergistic effects of thrombopoietin and granulocyte colony-stimulating factor on neutrophil recovery in myelosuppressed mice. Blood 1996a; 88: 3363–3370
   PubMed Web of Science ®Google Scholar
• Grossmann A., Lenox J., Ren H. P., Humes J. M., Forstrom J. W., Kaushansky K., Sprugel K. H. Thrombopoietin accelerates platelet, red blood cell, and neutrophil recovery in myelosuppressed mice. Exp. Hematol. 1996b; 24: 1238–1246
   PubMed Web of Science ®Google Scholar
• Gurney A. L., Carver-Moore K., deSauvage F. J., Moore M. W. Thrombocytopenia in c-mpl-deficient mice. Science 1994; 265: 1445–1447
   PubMed Web of Science ®Google Scholar
• Gurney A. L., Wong S. C., Henzel W. J., deSauvage F. J. Distinct regions of c-Mpl cytoplasmic domain are coupled to the JAK-STAT signal transduction pathway and She phosphorylation. Proc. Natl. Acad. Sci. USA 1995; 92: 5292–5296
   PubMed Web of Science ®Google Scholar
• Harker L. A., Hunt P., Marzec U. M., Kelly A. B., Tomer A., Hanson S. R., Stead R. B. Regulation of platelet production and function by megakaryocyte growth and development factor in nonhuman primates. Blood 1996a; 87: 1833–1844
   PubMed Web of Science ®Google Scholar
• Harker L. A., Marzec U. M., Hunt P., Kelly A. B., Tomer A., Cheung E., Hanson S. R., Stead R. B. Dose-response effects of pegylated human megakaryocyte growth and development factor on platelet production and function in nonhuman primates. Blood 1996b; 88: 511–521
   PubMed Web of Science ®Google Scholar
• Harker L. A., Marzec U. M., Kelly A. B., Cheung E., Tomer A., Nichol J. L., Hanson S. A., Stead R. B. Prevention of thrombocytopenia and neutropenia in a non human primate model of marrow suppressive chemotherapy by combining pegylated human recombinant megakaryocyte growth and development factor and human recombinant granulocyte colony-stimulating factor. Blood 1997; 89: 155–165
   PubMed Web of Science ®Google Scholar
• Harker L. A., Marzec U. M., Novembre F., Sundell I. B., Waller E. K., Karpatkin S., McClure H. M., Kelly A. B., Stead R. B. Treatment of thrombocytopenia in chimpanzees infected with human immunodeficiency virus by pegylated recombinant human megakaryocyte growth and development factor. Blood 1998; 91: 4427–4433
   PubMed Web of Science ®Google Scholar
• Hill R. J., Zozulya S., Lu Y. L., Hollenbach P. W., Joyce-Shaikh B., Bogenberger J., Gishizky M. L. Differentiation induced by the c-Mpl cytokine receptor is blocked by mutant She adaptor protein. Cell Growth Diff. 1996; 7: 1125–1134
   PubMedGoogle Scholar
• Hokom M. M., Lacey D., Kinstler O. B., Choi E., Kaufman S., Faust J., Rowan C., Dwyer E., Nichol J. L., Grasel T., Wilson J., Stembrink R., Hecht R., Winters W., Boone T., Hunt P. Pegylated megakaryocyte growth and development factor abrogates the lethal thrombocytopenia associated with carboplatin and irradiation in mice. Blood 1995; 86: 4486–4492
   PubMed Web of Science ®Google Scholar
• Hong Y., Dumenil D., van der Loo B., Goncalves F., Vainchenker W., Erusalimsky J. D. Protein kinase C., mediates the mitogenic action of thrombopoietin in c-Mpl-expressing UT-7 cells. Blood 1998; 91: 813–822
   PubMed Web of Science ®Google Scholar
• Hunt P. The physiologic role and therapeutic potential of the Mpl-ligand in thrombopoiesis. Stem Cells 1995; 13: 579–587
   PubMed Web of Science ®Google Scholar
• Hunt P., Li Y. S., Nichol J. L. Purification and biologic characterization of plasma-derived megakaryocyte growth and development factor. Blood 1995; 86: 540–547
   PubMed Web of Science ®Google Scholar
• Kato T., Ogami K., Shimada Y., Iwamatsu A., Sohma Y., Akahori H., Horie K., Kokubo A., Kudo Y., Maeda E. Purification and characterization of thrombopoietin. J. Biochem. 1995; 118: 229–236
   PubMed Web of Science ®Google Scholar
• Kaushansky K., Broudy V. C., Grossmann A., Humes J., Lin N., Ren H. P., Bailey M. C., Pappayannopoulou T., Forstrom J. W., Sprugel K. H. Thrombopoietin expands erythroid progenitors, increases red cell production, and enhances erythroid recovery after myelosuppressive therapy. J. Clin. Invest. 1995; 96: 1683–1687
   PubMed Web of Science ®Google Scholar
• Kaushansky K., Lok S., Holly R. D., Broudy V. C., Lin N., Bailey M. C., Forstrom J. W., Buddie M. M., Oort P. J., Hagen F. S., Roth C. J., Papayannopoulou T., Foster D. C. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature 1994; 369: 568–571
   PubMed Web of Science ®Google Scholar
• Keleman E., Cserhati I., Tanos B. Demonstration and some properties of human thrombopoietin in thrombocytopenic sera. Acta Hematol. 1958; 20: 350–353
   PubMedGoogle Scholar
• Kimura S., Roberts A. W., Metcalf D., Alexander W. S. Hematopoietic stem cell deficiencies in mice lacking c-Mpl, the receptor for thrombopoietin. Proc. Natl. Acad. Sci. USA 1998; 95: 1195–1200
   PubMed Web of Science ®Google Scholar
• Kobayashi M., Laver J. H., Kato T., Miyazaki H., Ogawa M. Recombinant human thrombopoietin (Mpl ligand) enhances proliferation of erythroid progenitors. Blood 1996; 86: 2494–2499
   Google Scholar
• Ku H., Yonemura Y., Kaushanski K., Ogawa M. Thrombopoietin, the ligand for the Mpl receptor, synergizes with Steel factor and other early-acting cytokines in supporting proliferation of primitive hematopoietic progenitors of mice. Blood 1996; 87: 4544–4551
   PubMed Web of Science ®Google Scholar
• Kuter P. L., Beeler D. L., Rosenberg R. D. The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production. Proc. Natl. Acad. Sci. USA 1994; 91: 11104–11108
   PubMed Web of Science ®Google Scholar
• Leven R. M., Yee M. K. Megakaryocyte morphogenesis stimulated in vitro by whole and partially fractionated thrombocytopenic plasma: a model system for the study of platelet formation. Blood 1987; 69: 1046–1052
   PubMed Web of Science ®Google Scholar
• Linden H., Kaushansky K. The glycan domain od thrombopoietin (TPO) functions alone in trans to enhance secretion of the receptor binding domain of TPO and other cytokines. Blood 1998; 92(suppl. 1)674a
   Google Scholar
• Lok S., Kaushansky K., Holly R. D., Kuijper J. L., Lofton-Day C. E., Oort P. J., Grant F. J., Heipel M. D., Buckhead S. K., Kramer J. M., Bell L. A., Sprecher C. A., Blumberg H., Johnson R., Prunkard D., Ching A. F.T., Mathewes S. L., Bailey M. C., Forstrom J. W., Osborn M. M., Osborn S. G., EvansSheppard S. J.P.O., Presnell S. R.O, Hara P. J., Hagen F. S., Roth G. J., Foster D. C. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet productio. in vivo. Nature 1994; 369: 565–568
   PubMed Web of Science ®Google Scholar
• Long M. W., Williams N., Ebbe S. Immature megakaryocytes in the mouse: Physical characteristics, cell cycle status, and in vitro responsiveness to thrombopoietic stimulatory factor. Blood 1982; 59: 569–575
   PubMed Web of Science ®Google Scholar
• Luens K. M., Travis M. A., Chen B. P., Hill B. L., Scollay R., Murray L. J. Thrombopoietin, kit ligand, and flk2/flt3 ligand together induce increased numbers of primitive hematopoietic progenitors from human CD34 + Thy-1 + Lin-cells with preserved ability to engraft SCID-hu bone. Blood 1998; 91: 91–1206
   Web of Science ®Google Scholar
• Matsumura I., Nakajima K., Wakao H., Hattori S., Hashimoto K., Sugahara H., Kato T., Miyazaki H., Hirano T., Kanakura Y. Involvement of prolonged ras activation in thrombopoietin-induced megakaryocyte differentiation of a human factor-dependent hematopoietic cell line. Mol. Cell. Biol. 1998; 18: 4282–4290
   PubMed Web of Science ®Google Scholar
• Matsunaga T., Kato T., Miyazaki H., Ogawa M. Thrombopoietin promotes the survival of murine hematopoietic long-term reconstituting cells: comparison with the effects of FLT3/FLK-2 ligand and interleukin-6. Blood 1998; 92: 452–461
   PubMed Web of Science ®Google Scholar
• McCarty J. M., Sprugel K. H., Fox N. E., Sabath D. E., Kaushansky K. Murine thrombopoietin mRNA levels are modulated by platelet count. Blood 1995; 86: 3668–3675
   PubMed Web of Science ®Google Scholar
• Miyakawa Y., Oda A., Druker B. J., Kato T., Miyazaki H., Handa M., Ikeda Y. Recombinant thrombopoietin induces rapid protein tyrosine phosphorylation of Janus kinase 2 and She in human blood platelets. Blood 1995; 86: 23–27
   PubMed Web of Science ®Google Scholar
• Miyakawa Y., Oda A., Druker B. J., Miyazaki H., Handa M., Ohashi H., Ikeda Y. Thrombopoietin induces tyrosine phosphorylation of STAT3 and STAT5 in human blood platelets. Blood 1996; 87: 439–446
   PubMed Web of Science ®Google Scholar
• Miyakawa Y., Oda A., Druker B. J., Ozaki K., Handa M., Ohashi H., Ikeda Y. Thrombopoietin and thrombin induce tyrosine phosphorylation of Vav in human blood platelets. Blood 1997; 89: 2789–2798
   PubMed Web of Science ®Google Scholar
• Molineux G., Hartley C. A., McElroy P., McCrea C., McNiece I. K. Megakaryocyte growth and development factor stimulates enhanced platelet recovery in mice after bone marrow transplantation. Blood 1996; 88: 1509–1514
   PubMed Web of Science ®Google Scholar
• Montruccio G., Brizzi M. F., Calosso G., Marengo S., Pegoraro L., Camussi G. Effects of recombinant human megakaryocyte growth and development factor on platelet activation. Blood 1996; 87: 2762–2768
   PubMed Web of Science ®Google Scholar
• Morita H., Tahara T., Matsumoto A., Kato T., Miyazaki H., Ohashi H. Functional analysis of the cytoplasmic domain of the human Mpl receptor for tyrosine-phosphorylation of the signaling molecules, proliferation and differentiation. FEBS Lett. 1996; 395: 228–234
   PubMed Web of Science ®Google Scholar
• Mu S. X., Xia M., Elliot C., Bogenberger J., Swift S., Bennett L., Lappinga P. L., Hecht R., Lee R., Saris C. J. Megakaryocyte growth and development factor and interleukin-3 induce patterns of protein-tyrosine phosphorylation that correlate with dominant differentiation over proliferation of mpl-transfected 32D cells. Blood 1995; 86: 4532–4543
   PubMed Web of Science ®Google Scholar
• Nagahisa H., Nagata Y., Ohnuki T., Osada M., Nagasawa T., Abe T., Todokoro K. Bone marrow stromal cells produce thrombopoietin and stimulate megakaryocyte growth and maturation but suppress proplatelet formation. Blood 1996; 87: 87–1309
   Web of Science ®Google Scholar
• Nichol J. L., Hokom M. M., Hornkohl A., Sheridan W. P., Ohashi H., Kato T., Li Y. S., Bartley T. D., Choi E., Bogenberger J., Skrine J. D., Knudten A., Chen J., Trail G., Sleeman L., Cole S., Grampp G., Hunt P. Megakaryocyte growth and development factor. Analyses of in vitro effects on human megakaryopoiesis and endogenous serum levels during chemotherapy-induced thrombocytopenia. J. Clin. Invest. 1995; 95: 2973–2978
   PubMed Web of Science ®Google Scholar
• Nicola N. A. Guidebook to Cytokines and their Receptors. Oxford University Press, Oxford 1994
   Google Scholar
• Neelis K. J., Dubbeiman Y. D., Wognum A. W., Thomas G. R., Eaton D. L., Egeland T., Wagemaker G. Lack of efficacy of thrombopoietin and granulocyte colony-stimulating factor after high dose total-body irradiation and autologous stem cell or bone marrow transplantation in rhesus monkeys. Exp. Hematol. 1997a; 25: 1094–1103
   PubMed Web of Science ®Google Scholar
• Neelis K. J., Qingliang L., Thomas G. R., Cohen B. L., Eaton D. L., Wagemaker G. Prevention of thrombocytopenia by thrombopoietin in myelosuppressed rhesus monkeys accompanied by prominent erythropoietic stimulation and iron depletion. Blood 1997b; 90: 58–63
   PubMed Web of Science ®Google Scholar
• Neelis K. J., Visser T. P., Dimjati W., Thomas G. R., Fielder P. J., Bloedow D., Eaton D. L., Wagemaker G. A single dose of thrombopoietin shortly after myelo-suppressive total body irradiation prevents pancytopenia in mice by promoting short-term multilineage spleen-repopulating cells at the transient expense of bone marrow-repopulating cells. Blood 1998; 92: 1586–1597
   PubMed Web of Science ®Google Scholar
• Oda A., Miyakawa Y., Druker B. J., Ozaki K., Yabusaki K., Shirasawa Y., Handa M., Kato T., Miyazaki H., Shimosaka A., Ikeda Y. Thrombopoietin primes human platelet aggregation induced by shear stress and by multiple agonists. Blood 1996; 87: 4664–4670
   PubMed Web of Science ®Google Scholar
• O'Malley C. J., Rasko J. E.J., Basser R. L., McGrath K. M., Cebon J., Grigg A. P., Hopkins W., Cohen B. O., Byrne J., Green M. D., Fox R. M., Berndt M. C., Begley C. G. Administration of pegylated recombinant human megakaryocyte growth and development factor to humans stimulates the production of functional platelets that show no evidence of in vivo activation. Blood 1996; 88: 3288–3298
   PubMed Web of Science ®Google Scholar
• Ozaki K., Oda A., Wakao H., Rhodes J., Druker B. J., Ishida A., Wakui M., Okamoto S., Morita K., Handa M., Komatsu N., Ohashi H., Miyajima A., Ikeda Y. Thrombopoietin induces association of Crkl with STAT5 but not STAT3 in human platelets. Blood 1998; 92: 4652–4662
   PubMed Web of Science ®Google Scholar
• Pallard C., Goullineux F., Benit L., Cocault L., Souyri M., Levy D., Groner B., Gisselbrecht S., Dusanter-Fourt I. Thrombopoietin activates a STAT5-like factor in hematopoietic cells. EM BO J. 1995; 14: 2847–2856
   PubMed Web of Science ®Google Scholar
• Porteu F., Rouyez M.-C, Cocault L., Benit L., Charon M., Picard F., Gisselbrecht S., Souyri M., Dusanter-Fourt I. Functional regions of the mouse thrombopoietin receptor cytoplasmic domain: evidence for a critical region which is involved in differentiation and can be complemented by erythropoietin. Mol. Cell. Biol. 1996; 16: 2473–2482
   PubMed Web of Science ®Google Scholar
• Ramsfjell V., Borge O. J., Veiby O. P., Cardier J., Murphy M. J., Jr., Lyman S. D., Lok S., Jacobsen S. E.W. Thrombopoieitin but not erythropoietin directly stimulates multilineage growth of primitive murine bone marrow progenitor cells in synergy with early acting cytokines: distinct interactions with the ligands for c-kit and FLT3. Blood 1996; 88: 4481–4492
   PubMed Web of Science ®Google Scholar
• Rasko J. E.J., Basser R. L., Boyd J., Mansfield R. O., Malley C. J., Hussein S., Berndt M. C., Clarke K. O., Byrne J., Sheridan W. P., Grigg A. P., Begley C. G. Multilineage mobilisation of peripheral blood progenitor cells in humans following administration of PEG-rHuMGDF. Br. J. Haematol. 1997a; 97: 871–880
   PubMed Web of Science ®Google Scholar
• Rasko J. E.J.O, Flaherty E., Begley C. G. Mplligand (MGDF) alone and in combination with stem cell factor (SCF) promotes proliferation and survival of human megakaryocyte. erythroid and granulocyte/macrophage progenitors. Stem Cells 1997b; 15: 33–42
   PubMed Web of Science ®Google Scholar
• Rouyez M. C., Boucheron C., Gisselbrecht S., Dusanter-Fourt I., Porteu F. Control of thrombopoietin-induced megakaryocytic differentiation by the mitogen-activated protein kinase pathway. Mol. Cell Biol. 1997; 17: 4991–5000
   PubMed Web of Science ®Google Scholar
• Sasaki K., Odai H., Hanazono Y., Ueno FL, Ogawa S., Langdon W. Y., Tanaka T., Miyagawa K., Mitani K., Yazaki Y., Hirai H. TPO/c-Mpl ligand induces tyrosine phosphorylation of multiple cellular proteins including proto-oncogene products Vav and c-Cbl, and Ras signaling molecules. Biochem. Biophys. Res. Commun. 1995; 216: 338–347
   PubMed Web of Science ®Google Scholar
• Sattler M., Durstin M. A., Frank D. A., Okuda K., Kaushansky K., Salgia R., Griffin J. D. The thrombopoietin receptor c-Mpl acivates Jak2 and Tyk2 tyrosine kinases. Exp. Hematol. 1995; 23: 1040–1048
   PubMed Web of Science ®Google Scholar
• Shibuya K., Akahori H., Tahara E., Kato T., Miyazaki H. Pegylated recombinant human megakaryocyte growth and development factor effectively improves thrombocytopenia in an a murine model of idiopathic thrombocytopenia (NZW × BXSB)F1. Blood 1998a; 10(suppl. 1)376a
   Google Scholar
• Shibuya K., Akahori H., Takahashi K., Tahara E., Kato T., Miyazaki H. Multilineage hematopoietic recovery by a single injection of pegylated recombinant human megakaryocyte growth and development factor in myelosuppressed mice. Blood 1998b; 91: 91–37
   Web of Science ®Google Scholar
• Shivdasani R. A., Kosenblatt M. F., Zucker-Franklin D., Jackson C. W., Hunt P., Saris C. J., Orkin S. H. Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development. Cell 1995; 81: 81–695
   Web of Science ®Google Scholar
• Sitmcka E., Lin N., Priestley G. V., Fox N., Broudy V. C., Wolf N. S., Kaushansky K. The effect of thrombopoietin on the proliferation and differentiation of murine hematopoietic stem cells. Blood 1996; 81: 4998–5005
   Google Scholar
• Sohma Y., Akahori H., Seki N., Hori T., Ogami K., Kato T., Shimada Y., Kawamura K., Miyazaki H. Molecular cloning and chromosomal localisation of the human thrombopoietin gene. FEBS Lett. 1994; 353: 57–61
   PubMed Web of Science ®Google Scholar
• Solar G. P., Kerr W. G., Zeigler F. C., Hess D., Donahue C., deSauvage F. J., Eaton D. L. Role of c-mpl in early hematopoiesis. Blood 1998; 92: 4–10
   PubMed Web of Science ®Google Scholar
• Souyri M., Vigon I., Penciolelli J.-F., Heard J.-M., Tambourin P., Wendling F. A putative truncated cytokine receptor gene transduced by the myeloproliferative leukemia virus immortalizes hematopoietic progenitors. Cell 1990; 63: 1137–1147
   PubMed Web of Science ®Google Scholar
• Stefanich E., Senn T., Widmer R., Fratino C., Keller G. A., Fielder P. J. Metabolism of thrombopoietin (TPO) in vivo: determination of the binding dynamics for TPO in mice. Blood 1997; 89: 4063–4070
   PubMed Web of Science ®Google Scholar
• Stoffel R., Wiestner A., Skoda R. C. Thrombopoietin in thrombocytopenic mice: evidence against regulation at the mRNA level and for a direct regulatory role of platelets. Blood 1996; 87: 567–573
   PubMed Web of Science ®Google Scholar
• Sungaran R., Markovic B., Chong B. H. Localization and regulation of thrombopoietin mRNA expression in human kidney, liver, bone marrow, and spleen using in situ hybridization. Blood 1996; 89: 101–107
   Web of Science ®Google Scholar
• Takatoku M., Kametaka M., Shimizu R., Miura Y., Komatsu N. Identification of functional domains of the human thrombopoietin receptor required for growth and differentiation of megakaryocytic cells. J. Biol. Chem. 1997; 272: 7259–7263
   PubMed Web of Science ®Google Scholar
• Toombs C. F., Young C. H., Glaspy J. A., Varnum B. C. Megakaryocyte growth and development factor (MGDF) moderately enhances in-vitro platelet aggregation. Thromb. Res. 1995; 80: 23–33
   PubMed Web of Science ®Google Scholar
• Tortolani P. J., Johnston J. A., Bacon C. M., McVicar D. W., Shimosaka A., Linnekin D., Longo D. L.O., Shea J. J. Thrombopoietin induces tyrosine phosphorylation and activation of the Janus kinase JAK2. Blood 1995; 85: 3444–3451
   PubMed Web of Science ®Google Scholar
• Ulich T. R., delCastillo J., Senaldi G., Kinstler O., Yin S., Kaufman S., Tarpley J., Choi E., Kirley T., Hunt P., Sheridan W. P. Systemic hematologic effects of PEG-rHuMGDF-induced megakaryocyte hyperplasia in mice. Blood 1996; 87: 5006–5015
   PubMed Web of Science ®Google Scholar
• Ulich T. R., delCastillo J., Yin S., Swift S., Padilla D., Senaldi G., Bennett L., Shutter J., Bogenberger J., Sun D., Samal B., Shimamoto G., Lee R., Steinbrink K., Boone T., Sheridan W. T., Hunt P. Megakaryocyte growth and development factor ameliorates carboplatin-induced thrombocytopenia in mice. Blood 1995; 86: 971–976
   PubMed Web of Science ®Google Scholar
• Vadhan-Raj S. Recombinant human thrombopoietin: clinical experience and in vivo biology. Seminars Hematol. 1998; 35: 261–268
   PubMed Web of Science ®Google Scholar
• Vadhan-Raj S., Murray L. J., Bueso-Ramos C., Patel S., Reddy S. P., Hoots W. K., Johnston T., Papadopolous N. E., Hittelman W. N., Johnston D. A., Yang T. A., Paton V. E., Cohen R. L., Hellmann S. D., Benjaminm R. S., Broxmeyer H. E. Stimulation of megakaryocyte and platelet production of a single dose of recombinant human thrombopoietin in patients with cancer. Ann. Int. Med. 1997; 126: 673–681
   PubMed Web of Science ®Google Scholar
• Wendling F., Varlet P., Charon M., Tambourin P. MPLV: a retrovirus complex inducing an acute myeloproliferative leukemic disorder in adult mice. Virology 1986; 149: 242–246
   PubMed Web of Science ®Google Scholar
• Yamashita Y., Miyazato A., Shimizu R., Komatsu N., Miura Y., Ozawa K., Mano H. Tec proteintyrosine kinase is involved in the thrombopoietin/c-Mpl signaling pathway. Exp. Hematol. 1997; 25: 211–216
   PubMed Web of Science ®Google Scholar
• Young J. C., Bruno E., Luens K. M., Wu S., Backer M., Murray L. J. Thrombopoietin stimulates megakaryocytopoiesis, myelopoiesis, and expansion of CD34+ progenitor cells from single CD34+Thy-1 +Lin- primitive progenitor cells. Blood 1996; 88: 1619–1631
   PubMed Web of Science ®Google Scholar